These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23800945)

  • 1. Bofutsushosan, a Japanese herbal (Kampo) medicine, attenuates progression of nonalcoholic steatohepatitis in mice.
    Ono M; Ogasawara M; Hirose A; Mogami S; Ootake N; Aritake K; Higuchi T; Okamoto N; Sakamoto S; Yamamoto M; Urade Y; Saibara T; Oben JA
    J Gastroenterol; 2014 Jun; 49(6):1065-73. PubMed ID: 23800945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel and comprehensive mouse model of human non-alcoholic steatohepatitis with the full range of dysmetabolic and histological abnormalities induced by gold thioglucose and a high-fat diet.
    Ogasawara M; Hirose A; Ono M; Aritake K; Nozaki Y; Takahashi M; Okamoto N; Sakamoto S; Iwasaki S; Asanuma T; Taniguchi T; Urade Y; Onishi S; Saibara T; Oben JA
    Liver Int; 2011 Apr; 31(4):542-51. PubMed ID: 21382165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis.
    Handa P; Maliken BD; Nelson JE; Morgan-Stevenson V; Messner DJ; Dhillon BK; Klintworth HM; Beauchamp M; Yeh MM; Elfers CT; Roth CL; Kowdley KV
    Hepatology; 2014 Jul; 60(1):133-45. PubMed ID: 24464605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
    Abd El-Haleim EA; Bahgat AK; Saleh S
    Eur J Pharmacol; 2016 Feb; 773():59-70. PubMed ID: 26825546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of
    Nishiyama M; Ohtake N; Kaneko A; Tsuchiya N; Imamura S; Iizuka S; Ishizawa S; Nishi A; Yamamoto M; Taketomi A; Kono T
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32245128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic metabolic adaptation and adipose tissue expansion are altered in mice with steatohepatitis induced by high-fat high sucrose diet.
    Baiges-Gaya G; Fernández-Arroyo S; Luciano-Mateo F; Cabré N; Rodríguez-Tomàs E; Hernández-Aguilera A; Castañé H; Romeu M; Nogués MR; Camps J; Joven J
    J Nutr Biochem; 2021 Mar; 89():108559. PubMed ID: 33264665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms for the anti-obesity actions of bofutsushosan in high-fat diet-fed obese mice.
    Kobayashi S; Kawasaki Y; Takahashi T; Maeno H; Nomura M
    Chin Med; 2017; 12():8. PubMed ID: 28360931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts.
    Koh YC; Lin YC; Lee PS; Lu TJ; Lin KY; Pan MH
    Food Funct; 2020 Sep; 11(9):7545-7560. PubMed ID: 32815965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
    Chai C; Cox B; Yaish D; Gross D; Rosenberg N; Amblard F; Shemuelian Z; Gefen M; Korach A; Tirosh O; Lanton T; Link H; Tam J; Permyakova A; Ozhan G; Citrin J; Liao H; Tannous M; Hahn M; Axelrod J; Arretxe E; Alonso C; Martinez-Arranz I; Betés PO; Safadi R; Salhab A; Amer J; Tber Z; Mengshetti S; Giladi H; Schinazi RF; Galun E
    Gastroenterology; 2020 Sep; 159(3):999-1014.e9. PubMed ID: 32450149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice.
    Honda T; Ishigami M; Luo F; Lingyun M; Ishizu Y; Kuzuya T; Hayashi K; Nakano I; Ishikawa T; Feng GG; Katano Y; Kohama T; Kitaura Y; Shimomura Y; Goto H; Hirooka Y
    Metabolism; 2017 Apr; 69():177-187. PubMed ID: 28285648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of Japanese herbal medicines sho-saiko-to and juzen-taiho-to on nonalcoholic steatohepatitis in mice.
    Takahashi Y; Soejima Y; Kumagai A; Watanabe M; Uozaki H; Fukusato T
    PLoS One; 2014; 9(1):e87279. PubMed ID: 24466347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ping-tang Recipe () improves insulin resistance and attenuates hepatic steatosis in high-fat diet-induced obese rats.
    Yang SY; Zhao NJ; Li XJ; Zhang HJ; Chen KJ; Li CD
    Chin J Integr Med; 2012 Apr; 18(4):262-8. PubMed ID: 22457136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
    Duan X; Meng Q; Wang C; Liu Z; Liu Q; Sun H; Sun P; Yang X; Huo X; Peng J; Liu K
    Phytomedicine; 2017 Feb; 25():83-92. PubMed ID: 28190475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Japanese herbal medicines shosaikoto, inchinkoto, and juzentaihoto inhibit high-fat diet-induced nonalcoholic steatohepatitis in db/db mice.
    Takahashi Y; Soejima Y; Kumagai A; Watanabe M; Uozaki H; Fukusato T
    Pathol Int; 2014 Oct; 64(10):490-8. PubMed ID: 25229199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis.
    Duparc T; Briand F; Trenteseaux C; Merian J; Combes G; Najib S; Sulpice T; Martinez LO
    Am J Physiol Gastrointest Liver Physiol; 2019 Oct; 317(4):G508-G517. PubMed ID: 31460789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ameliorative effect of bofutsushosan (Fangfengtongshengsan) extract on the progression of aging-induced obesity.
    Saeki T; Yamamoto S; Akaki J; Tanaka T; Nakasone M; Ikeda H; Wang W; Inoue M; Manse Y; Ninomiya K; Morikawa T
    J Nat Med; 2024 Jun; 78(3):576-589. PubMed ID: 38662301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.
    Luo Y; Burrington CM; Graff EC; Zhang J; Judd RL; Suksaranjit P; Kaewpoowat Q; Davenport SK; O'Neill AM; Greene MW
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E418-39. PubMed ID: 26670487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection from non-alcoholic steatohepatitis and liver tumourigenesis in high fat-fed insulin receptor substrate-1-knockout mice despite insulin resistance.
    Nakamura A; Tajima K; Zolzaya K; Sato K; Inoue R; Yoneda M; Fujita K; Nozaki Y; Kubota KC; Haga H; Kubota N; Nagashima Y; Nakajima A; Maeda S; Kadowaki T; Terauchi Y
    Diabetologia; 2012 Dec; 55(12):3382-91. PubMed ID: 22955994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice.
    Wahlang B; Falkner KC; Gregory B; Ansert D; Young D; Conklin DJ; Bhatnagar A; McClain CJ; Cave M
    J Nutr Biochem; 2013 Sep; 24(9):1587-95. PubMed ID: 23618531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.